BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20230453)

  • 1. Aprepitant vs. multimodal prophylaxis in the prevention of nausea and vomiting following extended-release epidural morphine.
    Hartrick CT; Tang YS; Hunstad D; Pappas J; Muir K; Pestano C; Silvasi D
    Pain Pract; 2010; 10(3):245-8. PubMed ID: 20230453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
    Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-controlled analgesia combined with either ondansetron or ondansetron plus prochlorperazine for control of pain and nausea and vomiting in patients undergoing abdominal surgery.
    Jellish WS; Owen K; Fluder E; Sawicki K; Sinacore J
    J Clin Anesth; 2008 Dec; 20(8):594-600. PubMed ID: 19100932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiemetic efficacy of combined aprepitant and dexamethasone in patients at high-risk of postoperative nausea and vomiting from epidural fentanyl analgesia.
    Kawano H; Matsumoto T; Hamaguchi E; Manabe S; Nakagawa M; Yamada A; Fujimoto M; Tada F
    Minerva Anestesiol; 2015 Apr; 81(4):362-8. PubMed ID: 25220550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Carides G; Elmer M; Schmidt C; Evans JK; Horgan KJ
    J Clin Oncol; 2003 Nov; 21(22):4105-11. PubMed ID: 14559891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metoclopramide and dexamethasone in prevention of postoperative nausea and vomiting after inhalational anaesthesia].
    Wallenborn J; Rudolph C; Gelbrich G; Goerlich TM; Döhnert J; Dörner J; Olthoff D
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Nov; 38(11):695-704. PubMed ID: 14600859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
    Gan TJ; Apfel CC; Kovac A; Philip BK; Singla N; Minkowitz H; Habib AS; Knighton J; Carides AD; Zhang H; Horgan KJ; Evans JK; Lawson FC;
    Anesth Analg; 2007 May; 104(5):1082-9, tables of contents. PubMed ID: 17456656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Aprepitant in Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery.
    Therneau IW; Martin EE; Sprung J; Kellogg TA; Schroeder DR; Weingarten TN
    Obes Surg; 2018 Jan; 28(1):37-43. PubMed ID: 28674839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors and frequency of postoperative nausea and vomiting in patients operated under general anesthesia].
    Grabowska-Gaweł A; Porzych K; Piskunowicz G
    Przegl Lek; 2006; 63(2):72-6. PubMed ID: 16969906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant.
    Diemunsch P; Apfel C; Gan TJ; Candiotti K; Philip BK; Chelly J; Carides AD; Evans JK; Ho TW; Reiss T
    Curr Med Res Opin; 2007 Oct; 23(10):2559-65. PubMed ID: 17845742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
    Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
    Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
    Danner K; Becker HG; Best B; Madler C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control.
    Tzeng JI; Chu KS; Ho ST; Cheng KI; Liu KS; Wang JJ
    Can J Anaesth; 2003 Dec; 50(10):1023-6. PubMed ID: 14656780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery.
    Krobbuaban B; Pitakpol S; Diregpoke S
    J Med Assoc Thai; 2008 May; 91(5):669-74. PubMed ID: 18672630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
    Warr DG; Hesketh PJ; Gralla RJ; Muss HB; Herrstedt J; Eisenberg PD; Raftopoulos H; Grunberg SM; Gabriel M; Rodgers A; Bohidar N; Klinger G; Hustad CM; Horgan KJ; Skobieranda F
    J Clin Oncol; 2005 Apr; 23(12):2822-30. PubMed ID: 15837996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis.
    Habib AS; Chen YT; Taguchi A; Hu XH; Gan TJ
    Curr Med Res Opin; 2006 Jun; 22(6):1093-9. PubMed ID: 16846542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-Cesarean analgesia.
    Wang JJ; Ho ST; Wong CS; Tzeng JI; Liu HS; Ger LP
    Can J Anaesth; 2001 Feb; 48(2):185-90. PubMed ID: 11220429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.